News
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...
Axios on MSN1d
Pfizer signs giant cancer drug deal with Chinese biotechPfizer on Tuesday announced a cancer drug licensing deal with Chinese biotech 3SBio that includes a $1.25 billion upfront ...
Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to ...
FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...
AmplifyBio said in a statement April 4, saying the decision to close followed months of efforts to keep the four-year-old firm afloat.
New Orleans biotech South Rampart Pharma advances non-opioid pain drug with $8M funding from Ochsner Ventures and Gulf South ...
Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...
Chicago’s life sciences market is the smallest of any major U.S. market by square footage yet has a vacancy rate of 43.3 ...
Point Loma Nazarene University has launched the Biotech Pathway Scholarship, which covers full tuition and fees for two years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback